Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 20378 | 463 | 27.7 | 69% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 1 | 4 | ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL | 3876184 |
| 154 | 3 | PSYCHIATRY//ALEXITHYMIA//PSYCHIAT | 62481 |
| 207 | 2 | PSYCHIATRY//ANTIDEPRESSANTS//DEPRESSION | 21074 |
| 20378 | 1 | BUPROPION//HYDROXYBUPROPION//THREOHYDROBUPROPION | 463 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | BUPROPION | authKW | 2634149 | 37% | 24% | 169 |
| 2 | HYDROXYBUPROPION | authKW | 794139 | 4% | 71% | 17 |
| 3 | THREOHYDROBUPROPION | authKW | 329751 | 1% | 100% | 5 |
| 4 | 4 HYDROXYBUPROPION | authKW | 263800 | 1% | 100% | 4 |
| 5 | WELLBUTRIN | authKW | 263796 | 1% | 67% | 6 |
| 6 | BUPROPION HYDROCHLORIDE | authKW | 215430 | 2% | 47% | 7 |
| 7 | ZYBAN R | authKW | 197850 | 1% | 100% | 3 |
| 8 | ZYBAN | authKW | 197844 | 1% | 50% | 6 |
| 9 | BUPROPION METABOLITE | authKW | 131900 | 0% | 100% | 2 |
| 10 | ERYTHROHYDROBUPROPION | authKW | 131900 | 0% | 100% | 2 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Pharmacology & Pharmacy | 3173 | 48% | 0% | 224 |
| 2 | Psychiatry | 2773 | 28% | 0% | 131 |
| 3 | Psychology, Clinical | 921 | 10% | 0% | 48 |
| 4 | Emergency Medicine | 316 | 4% | 0% | 17 |
| 5 | Toxicology | 213 | 7% | 0% | 33 |
| 6 | Substance Abuse | 196 | 3% | 0% | 15 |
| 7 | Neurosciences | 95 | 11% | 0% | 50 |
| 8 | Chemistry, Analytical | 74 | 7% | 0% | 32 |
| 9 | Biochemical Research Methods | 47 | 4% | 0% | 20 |
| 10 | Chemistry, Medicinal | 44 | 4% | 0% | 17 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | ADV GEOMAT RD | 65950 | 0% | 100% | 1 |
| 2 | AFFILIATE ALLERGAN PLC | 65950 | 0% | 100% | 1 |
| 3 | ALLAN MEM PHARM UNIT | 65950 | 0% | 100% | 1 |
| 4 | CLIN TRANSALAT | 65950 | 0% | 100% | 1 |
| 5 | EARLY PHASE CRO | 65950 | 0% | 100% | 1 |
| 6 | FOODHILLS MED | 65950 | 0% | 100% | 1 |
| 7 | GOBAL DEV | 65950 | 0% | 100% | 1 |
| 8 | MEDBK PROJECT 21 | 65950 | 0% | 100% | 1 |
| 9 | MENTAL HEALTH CORRECT MANAGED CARE | 65950 | 0% | 100% | 1 |
| 10 | NEUROSCI PHYSIOLUNIT PHARMACOKINET DRUG | 65950 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | JOURNAL OF CLINICAL PSYCHIATRY | 20568 | 10% | 1% | 47 |
| 2 | HOSPITAL PHARMACY | 9420 | 0% | 14% | 1 |
| 3 | MODERN PROBLEMS OF PHARMACOPSYCHIATRY | 4395 | 0% | 7% | 1 |
| 4 | JOURNAL OF ADDICTION MEDICINE | 3483 | 1% | 1% | 5 |
| 5 | PHARMACOPSYCHIATRY | 2093 | 2% | 0% | 8 |
| 6 | DRUG METABOLISM AND DISPOSITION | 1703 | 3% | 0% | 14 |
| 7 | PSYCHOPHARMAKOTHERAPIE | 1188 | 1% | 1% | 3 |
| 8 | CLINICAL TOXICOLOGY | 1100 | 1% | 0% | 5 |
| 9 | PSYCHOPHARMACOLOGY | 1050 | 3% | 0% | 14 |
| 10 | KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY | 1003 | 1% | 1% | 3 |
Author Key Words |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | BUPROPION | 2634149 | 37% | 24% | 169 | Search BUPROPION | Search BUPROPION |
| 2 | HYDROXYBUPROPION | 794139 | 4% | 71% | 17 | Search HYDROXYBUPROPION | Search HYDROXYBUPROPION |
| 3 | THREOHYDROBUPROPION | 329751 | 1% | 100% | 5 | Search THREOHYDROBUPROPION | Search THREOHYDROBUPROPION |
| 4 | 4 HYDROXYBUPROPION | 263800 | 1% | 100% | 4 | Search 4+HYDROXYBUPROPION | Search 4+HYDROXYBUPROPION |
| 5 | WELLBUTRIN | 263796 | 1% | 67% | 6 | Search WELLBUTRIN | Search WELLBUTRIN |
| 6 | BUPROPION HYDROCHLORIDE | 215430 | 2% | 47% | 7 | Search BUPROPION+HYDROCHLORIDE | Search BUPROPION+HYDROCHLORIDE |
| 7 | ZYBAN R | 197850 | 1% | 100% | 3 | Search ZYBAN+R | Search ZYBAN+R |
| 8 | ZYBAN | 197844 | 1% | 50% | 6 | Search ZYBAN | Search ZYBAN |
| 9 | BUPROPION METABOLITE | 131900 | 0% | 100% | 2 | Search BUPROPION+METABOLITE | Search BUPROPION+METABOLITE |
| 10 | ERYTHROHYDROBUPROPION | 131900 | 0% | 100% | 2 | Search ERYTHROHYDROBUPROPION | Search ERYTHROHYDROBUPROPION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | DWOSKIN, LP , RAUHUT, AS , KING-POSPISIL, KA , BARDO, MT , (2006) REVIEW OF THE PHARMACOLOGY AND CLINICAL PROFILE OF BUPROPION, AN ANTIDEPRESSANT AND TOBACCO USE CESSATION AGENT.CNS DRUG REVIEWS. VOL. 12. ISSUE 3-4. P. 178-207 | 81 | 44% | 114 |
| 2 | GUFFORD, BT , LU, JB , METZGER, IF , JONES, DR , DESTA, Z , (2016) STEREOSELECTIVE GLUCURONIDATION OF BUPROPION METABOLITES IN VITRO AND IN VIVO.DRUG METABOLISM AND DISPOSITION. VOL. 44. ISSUE 4. P. 544 -553 | 30 | 71% | 7 |
| 3 | MASTERS, AR , GUFFORD, BT , LU, JBL , METZGER, IF , JONES, DR , DESTA, Z , (2016) CHIRAL PLASMA PHARMACOKINETICS AND URINARY EXCRETION OF BUPROPION AND METABOLITES IN HEALTHY VOLUNTEERS.JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. VOL. 358. ISSUE 2. P. 230 -238 | 35 | 70% | 2 |
| 4 | MASTERS, AR , MCCOY, M , JONES, DR , DESTA, Z , (2016) STEREOSELECTIVE METHOD TO QUANTIFY BUPROPION AND ITS THREE MAJOR METABOLITES, HYDROXYBUPROPION, ERYTHRO-DIHYDROBUPROPION, AND THREO-DIHYDROBUPROPION USING HPLC-MS/MS.JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. VOL. 1015. ISSUE . P. 201 -208 | 25 | 89% | 2 |
| 5 | LAIB, AK , BRUNEN, S , PFEIFER, P , VINCENT, P , HIEMKE, C , (2014) SERUM CONCENTRATIONS OF HYDROXYBUPROPION FOR DOSE OPTIMIZATION OF DEPRESSED PATIENTS TREATED WITH BUPROPION.THERAPEUTIC DRUG MONITORING. VOL. 36. ISSUE 4. P. 473 -479 | 26 | 74% | 6 |
| 6 | RUIZ, JS , GIBERT, J , FRAILE, MG , ROBES, J , VALLEJO, J , IGLESIAS, C , IRIARTE, V , (2011) BUPROPION: EFFICACY AND SAFETY IN THE TREATMENT OF DEPRESSION.ACTAS ESPANOLAS DE PSIQUIATRIA. VOL. 39. ISSUE . P. 1 -25 | 48 | 42% | 4 |
| 7 | AL-ABRI, SA , ORENGO, JP , HAYASHI, S , THOREN, KL , BENOWITZ, NL , OLSON, KR , (2013) DELAYED BUPROPION CARDIOTOXICITY ASSOCIATED WITH ELEVATED SERUM CONCENTRATIONS OF BUPROPION BUT NOT HYDROXYBUPROPION.CLINICAL TOXICOLOGY. VOL. 51. ISSUE 10. P. 1230-1234 | 19 | 100% | 2 |
| 8 | STRIKE, M , HATCHER, S , (2015) BUPROPION INJECTION RESULTING IN TISSUE NECROSIS AND PSYCHOSIS: PREVIOUSLY UNDOCUMENTED COMPLICATIONS OF INTRAVENOUS BUPROPION USE DISORDER.JOURNAL OF ADDICTION MEDICINE. VOL. 9. ISSUE 3. P. 246 -250 | 19 | 90% | 3 |
| 9 | FOLEY, KF , DESANTY, KP , KAST, RE , (2006) BUPROPION: PHARMACOLOGY AND THERAPEUTIC APPLICATIONS.EXPERT REVIEW OF NEUROTHERAPEUTICS. VOL. 6. ISSUE 9. P. 1249-1265 | 53 | 37% | 76 |
| 10 | PAREKH, JM , SUTARIYA, DK , VAGHELA, RN , SANYAL, M , YADAV, M , SHRIVASTAV, PS , (2012) SENSITIVE, SELECTIVE AND RAPID DETERMINATION OF BUPROPION AND ITS MAJOR ACTIVE METABOLITE, HYDROXYBUPROPION, IN HUMAN PLASMA BY LC-MS/MS: APPLICATION TO A BIOEQUIVALENCE STUDY IN HEALTHY INDIAN SUBJECTS.BIOMEDICAL CHROMATOGRAPHY. VOL. 26. ISSUE 3. P. 314-326 | 21 | 81% | 7 |
Classes with closest relation at Level 1 |